When Validation Becomes the Bottleneck
Why Large Capital Projects Need a Different Operating Model In large pharmaceutical capital projects, speed is always a priority. But one part of the process still tends to slow everything down: commissioning, qualification and validation. The issue is not expertise. It is the way CQV is still often organised. On complex projects, paper-based workflows, sequential…
When Validation Becomes the Bottleneck Read More »
